<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/91363DD3-3DEA-4D93-93B7-7A44176DADCE"><gtr:id>91363DD3-3DEA-4D93-93B7-7A44176DADCE</gtr:id><gtr:name>Catholic University of Louvain</gtr:name><gtr:address><gtr:line1>3 Place L Pasteur</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Belgium</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/BCD05341-5D48-43F1-A505-C169496883A1"><gtr:id>BCD05341-5D48-43F1-A505-C169496883A1</gtr:id><gtr:name>University of Hong Kong</gtr:name><gtr:address><gtr:line1>Pok Fu Lam Road</gtr:line1><gtr:line4>Hong Kong</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Hong Kong</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/FA143EC1-E637-4E0C-80ED-0EA8ED214038"><gtr:id>FA143EC1-E637-4E0C-80ED-0EA8ED214038</gtr:id><gtr:name>University of Leuven</gtr:name><gtr:address><gtr:line1>Oude Markt 13</gtr:line1><gtr:line2>Box 5005</gtr:line2><gtr:region>outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/22FC5EB4-C5EC-4751-9C2E-7F03B1DC354B"><gtr:id>22FC5EB4-C5EC-4751-9C2E-7F03B1DC354B</gtr:id><gtr:name>University of Ulm</gtr:name><gtr:address><gtr:line1>Albert Einstein Allee 5</gtr:line1><gtr:line4>Ulm</gtr:line4><gtr:postCode>89081</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C7FBE408-C743-4AAC-9BC6-65E14BC8D2FD"><gtr:id>C7FBE408-C743-4AAC-9BC6-65E14BC8D2FD</gtr:id><gtr:name>Karolinska Institute</gtr:name><gtr:address><gtr:line1>Administration</gtr:line1><gtr:line4>Stockholm</gtr:line4><gtr:postCode>SE-171 77</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/52423922-8331-4312-A996-E4734BB4D688"><gtr:id>52423922-8331-4312-A996-E4734BB4D688</gtr:id><gtr:name>Utrecht University</gtr:name><gtr:address><gtr:line1>PO Box 80125</gtr:line1><gtr:line2>3508 TC Utrecht</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/B92C1E49-4D20-4A69-BDBE-BDEC1AE2A476"><gtr:id>B92C1E49-4D20-4A69-BDBE-BDEC1AE2A476</gtr:id><gtr:name>University Medical Centre Utrecht</gtr:name><gtr:address><gtr:line1>Unversity Medical Centre Utrecht</gtr:line1><gtr:line2>Rudolf Magnus Institute for Neuroscience</gtr:line2><gtr:line3>PO Box 85060</gtr:line3><gtr:postCode>NL-3508 AB</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Netherlands</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4A9426E3-7F35-48FC-BD72-3776C8F90A4A"><gtr:id>4A9426E3-7F35-48FC-BD72-3776C8F90A4A</gtr:id><gtr:name>Grants Admin Office</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9C932CFE-AAE2-4A8F-A53F-1C7EAC961997"><gtr:id>9C932CFE-AAE2-4A8F-A53F-1C7EAC961997</gtr:id><gtr:name>Harvard University</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/430A04B6-0F63-43BA-B78B-8DD4147CAF43"><gtr:id>430A04B6-0F63-43BA-B78B-8DD4147CAF43</gtr:id><gtr:name>University of Paris South 11</gtr:name><gtr:address><gtr:line1>Batiment 300</gtr:line1><gtr:line4>Orsay cedex</gtr:line4><gtr:line5>F-91405</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>France</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/B85C9507-1FE0-420C-BAC8-8DC91772F172"><gtr:id>B85C9507-1FE0-420C-BAC8-8DC91772F172</gtr:id><gtr:name>Kantonsspital St. Gallen</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/43D5B366-CC13-4795-A805-37D9E9DF5588"><gtr:id>43D5B366-CC13-4795-A805-37D9E9DF5588</gtr:id><gtr:name>Howard Hughes Medical Institute</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F3879A64-1F19-4F1B-9F13-2148EFBEC73D"><gtr:id>F3879A64-1F19-4F1B-9F13-2148EFBEC73D</gtr:id><gtr:name>Massachusetts General Hospital</gtr:name><gtr:address><gtr:line1>Massachusetts General Hospital</gtr:line1><gtr:line2>55 Fruit STreet</gtr:line2><gtr:postCode>MA 02114</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/48990B2D-6D88-4205-B3F4-58863EA78D0D"><gtr:id>48990B2D-6D88-4205-B3F4-58863EA78D0D</gtr:id><gtr:name>National Institute of Health and Medical Research (INSERM)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/43BEDA5F-E824-412D-A4AC-ED7F1139F5CC"><gtr:id>43BEDA5F-E824-412D-A4AC-ED7F1139F5CC</gtr:id><gtr:name>University of Turin</gtr:name><gtr:address><gtr:line1>Via Giuseppe Verdi 8</gtr:line1><gtr:postCode>I-10124</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9EED95BB-25DC-4032-8E45-C3EA7277E78A"><gtr:id>9EED95BB-25DC-4032-8E45-C3EA7277E78A</gtr:id><gtr:name>University of Milan</gtr:name><gtr:address><gtr:line1>Via Festa del Perdono 7</gtr:line1><gtr:postCode>20122</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Italy</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/03D8AFBB-3EA5-4885-B036-BD4F9F4F9849"><gtr:id>03D8AFBB-3EA5-4885-B036-BD4F9F4F9849</gtr:id><gtr:name>University of Sheffield</gtr:name><gtr:address><gtr:line1>Firth Court</gtr:line1><gtr:line2>Western Bank</gtr:line2><gtr:line4>Sheffield</gtr:line4><gtr:line5>South Yorkshire</gtr:line5><gtr:postCode>S10 2TN</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2718B5D3-B880-4C4C-A4A3-0E639BDA800E"><gtr:id>2718B5D3-B880-4C4C-A4A3-0E639BDA800E</gtr:id><gtr:name>BMI The Beaumont Hospital</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/EF6B1E83-9BAD-4ED0-B2A0-5E1A69687339"><gtr:id>EF6B1E83-9BAD-4ED0-B2A0-5E1A69687339</gtr:id><gtr:name>European Commission</gtr:name><gtr:address><gtr:line1>Wetstraat 200 / Rue de la Loi 200</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Belgium</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:department>Neurology</gtr:department><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/91363DD3-3DEA-4D93-93B7-7A44176DADCE"><gtr:id>91363DD3-3DEA-4D93-93B7-7A44176DADCE</gtr:id><gtr:name>Catholic University of Louvain</gtr:name><gtr:address><gtr:line1>3 Place L Pasteur</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Belgium</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/BCD05341-5D48-43F1-A505-C169496883A1"><gtr:id>BCD05341-5D48-43F1-A505-C169496883A1</gtr:id><gtr:name>University of Hong Kong</gtr:name><gtr:address><gtr:line1>Pok Fu Lam Road</gtr:line1><gtr:line4>Hong Kong</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Hong Kong</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/FA143EC1-E637-4E0C-80ED-0EA8ED214038"><gtr:id>FA143EC1-E637-4E0C-80ED-0EA8ED214038</gtr:id><gtr:name>University of Leuven</gtr:name><gtr:address><gtr:line1>Oude Markt 13</gtr:line1><gtr:line2>Box 5005</gtr:line2><gtr:region>outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/22FC5EB4-C5EC-4751-9C2E-7F03B1DC354B"><gtr:id>22FC5EB4-C5EC-4751-9C2E-7F03B1DC354B</gtr:id><gtr:name>University of Ulm</gtr:name><gtr:address><gtr:line1>Albert Einstein Allee 5</gtr:line1><gtr:line4>Ulm</gtr:line4><gtr:postCode>89081</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C7FBE408-C743-4AAC-9BC6-65E14BC8D2FD"><gtr:id>C7FBE408-C743-4AAC-9BC6-65E14BC8D2FD</gtr:id><gtr:name>Karolinska Institute</gtr:name><gtr:address><gtr:line1>Administration</gtr:line1><gtr:line4>Stockholm</gtr:line4><gtr:postCode>SE-171 77</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/52423922-8331-4312-A996-E4734BB4D688"><gtr:id>52423922-8331-4312-A996-E4734BB4D688</gtr:id><gtr:name>Utrecht University</gtr:name><gtr:address><gtr:line1>PO Box 80125</gtr:line1><gtr:line2>3508 TC Utrecht</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/B92C1E49-4D20-4A69-BDBE-BDEC1AE2A476"><gtr:id>B92C1E49-4D20-4A69-BDBE-BDEC1AE2A476</gtr:id><gtr:name>University Medical Centre Utrecht</gtr:name><gtr:address><gtr:line1>Unversity Medical Centre Utrecht</gtr:line1><gtr:line2>Rudolf Magnus Institute for Neuroscience</gtr:line2><gtr:line3>PO Box 85060</gtr:line3><gtr:postCode>NL-3508 AB</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Netherlands</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4A9426E3-7F35-48FC-BD72-3776C8F90A4A"><gtr:id>4A9426E3-7F35-48FC-BD72-3776C8F90A4A</gtr:id><gtr:name>Grants Admin Office</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9C932CFE-AAE2-4A8F-A53F-1C7EAC961997"><gtr:id>9C932CFE-AAE2-4A8F-A53F-1C7EAC961997</gtr:id><gtr:name>Harvard University</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/430A04B6-0F63-43BA-B78B-8DD4147CAF43"><gtr:id>430A04B6-0F63-43BA-B78B-8DD4147CAF43</gtr:id><gtr:name>University of Paris South 11</gtr:name><gtr:address><gtr:line1>Batiment 300</gtr:line1><gtr:line4>Orsay cedex</gtr:line4><gtr:line5>F-91405</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>France</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/B85C9507-1FE0-420C-BAC8-8DC91772F172"><gtr:id>B85C9507-1FE0-420C-BAC8-8DC91772F172</gtr:id><gtr:name>Kantonsspital St. Gallen</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/43D5B366-CC13-4795-A805-37D9E9DF5588"><gtr:id>43D5B366-CC13-4795-A805-37D9E9DF5588</gtr:id><gtr:name>Howard Hughes Medical Institute</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F3879A64-1F19-4F1B-9F13-2148EFBEC73D"><gtr:id>F3879A64-1F19-4F1B-9F13-2148EFBEC73D</gtr:id><gtr:name>Massachusetts General Hospital</gtr:name><gtr:address><gtr:line1>Massachusetts General Hospital</gtr:line1><gtr:line2>55 Fruit STreet</gtr:line2><gtr:postCode>MA 02114</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/48990B2D-6D88-4205-B3F4-58863EA78D0D"><gtr:id>48990B2D-6D88-4205-B3F4-58863EA78D0D</gtr:id><gtr:name>National Institute of Health and Medical Research (INSERM)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/43BEDA5F-E824-412D-A4AC-ED7F1139F5CC"><gtr:id>43BEDA5F-E824-412D-A4AC-ED7F1139F5CC</gtr:id><gtr:name>University of Turin</gtr:name><gtr:address><gtr:line1>Via Giuseppe Verdi 8</gtr:line1><gtr:postCode>I-10124</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9EED95BB-25DC-4032-8E45-C3EA7277E78A"><gtr:id>9EED95BB-25DC-4032-8E45-C3EA7277E78A</gtr:id><gtr:name>University of Milan</gtr:name><gtr:address><gtr:line1>Via Festa del Perdono 7</gtr:line1><gtr:postCode>20122</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Italy</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/03D8AFBB-3EA5-4885-B036-BD4F9F4F9849"><gtr:id>03D8AFBB-3EA5-4885-B036-BD4F9F4F9849</gtr:id><gtr:name>University of Sheffield</gtr:name><gtr:address><gtr:line1>Firth Court</gtr:line1><gtr:line2>Western Bank</gtr:line2><gtr:line4>Sheffield</gtr:line4><gtr:line5>South Yorkshire</gtr:line5><gtr:postCode>S10 2TN</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2718B5D3-B880-4C4C-A4A3-0E639BDA800E"><gtr:id>2718B5D3-B880-4C4C-A4A3-0E639BDA800E</gtr:id><gtr:name>BMI The Beaumont Hospital</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/EF6B1E83-9BAD-4ED0-B2A0-5E1A69687339"><gtr:id>EF6B1E83-9BAD-4ED0-B2A0-5E1A69687339</gtr:id><gtr:name>European Commission</gtr:name><gtr:address><gtr:line1>Wetstraat 200 / Rue de la Loi 200</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Belgium</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/41068207-27FE-4720-AF41-A707BEE62ACE"><gtr:id>41068207-27FE-4720-AF41-A707BEE62ACE</gtr:id><gtr:firstName>Ammar</gtr:firstName><gtr:surname>Al-Chalabi</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/62211B96-56AF-4672-8BA7-754E3F0AC07B"><gtr:id>62211B96-56AF-4672-8BA7-754E3F0AC07B</gtr:id><gtr:firstName>Christopher</gtr:firstName><gtr:otherNames>E</gtr:otherNames><gtr:surname>Shaw</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/D22A5B0F-1831-4520-9F53-AE40DC8AF059"><gtr:id>D22A5B0F-1831-4520-9F53-AE40DC8AF059</gtr:id><gtr:firstName>Pak</gtr:firstName><gtr:surname>Sham</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0600974"><gtr:id>29DA5086-BCE9-4912-81B7-9DF7B7B14823</gtr:id><gtr:title>An investigation of replicated genetic associations from a genome-wide study of sporadic MND.</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0600974</gtr:grantReference><gtr:abstractText>We are trying to find genes that make people likely to develop motor neuron disease (MND). This is a wasting disease in which an affected person becomes progressively paralysed over months until they are too weak to breathe.
We know that a few people with MND carry a genetic mutation. For most people with MND we think that certain common genetic variations might increase the risk in certain situations.
MND takes many forms and we do not know if they are really all the same underlying disease or several different conditions that happen to look the same. This makes gene-hunting difficult. Also, even though MND is quite common (about 1 in every 400 people will die from it), life expectancy is very poor and so at any one time there are not many affected people who can help with research.
We have successfully found a genetic signal for MND on chromosome 8 but we now need to pinpoint where the signal is coming from. If we can find out exactly what genetic variation in this area is responsible, we will understand more about MND and this will make it easier to develop a treatment.</gtr:abstractText><gtr:technicalSummary>Background:
Motor Neuron Disease (MND) is a fatal adult-onset neurological disorder that causes progressive muscle weakness gradually affecting the power of speech, swallowing and limb movement. There is significant disability from the outset and eventually patients are left immobile, unable to communicate or care for themselves. Relentless disease progression engenders feelings of hopelessness so that some people travel abroad seeking euthanasia. The only drug shown to impact on survival, riluzole, has only a modest effect in slowing disease progression and treatment is otherwise largely symptomatic. The mean age of onset is between 50-60 years, cutting short the productive lives of many individuals. Death from respiratory failure usually occurs within 3 years of symptom onset and only 4% of patients survive more than 10 years. Although it is commonly thought of as a rare disease, the lifetime risk is about 1 in 400, with 1 in 380 death certificates carrying this diagnosis in the UK, and since the risk increases with age, it will become more common as the population ages. At present the diagnosis of MND is a death sentence with a miserable disease course, making it one of the most feared illnesses in the developed world.
Previous findings:
In an MRC-funded study, we have performed a genome-wide association study using 300 case and 300 control samples and 2,336 microsatellite markers. The markers were targeted at both gene-dense regions using a method we developed, and at regions previously shown to be of interest in MND. A DNA pooling strategy was followed by individual genotyping of markers of interest. Of the markers analysed, all showed confirmed association in individuals, and one on chromosome 8 showed replicated association in two other populations, from Belgium and the USA.
Objective:
To identify the functional variant(s) associated with sporadic motor neuron disease in the region we have identified on chromosome 8
Methods:
We will analyse the MND-associated region with an informative set of tag-SNPs in UK samples, and fine-map the disease associated locus. We will identify the association peak and identify the strongest positional candidate genes and their functional variants. We will confirm the mapping in Belgian and US populations. This will allow us to examine functional effects of gene variants identified in the laboratory. In parallel with this, we will perform bioinformatics analysis of relevant DNA and protein sequences and expression studies of genotyped brains for secondary evidence (genomic convergence).</gtr:technicalSummary><gtr:fund><gtr:end>2010-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>350000</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Ulm</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>STRENGTH</gtr:description><gtr:id>F115A0F0-B903-48B3-B52C-4D40D2C6E3E7</gtr:id><gtr:impact>Please see form publications. The collaboration is multidisciplinary including genetics, epidemiology, epigenetics, statistics and bioinformatics</gtr:impact><gtr:outcomeId>545f8a9d977197.00636340-11</gtr:outcomeId><gtr:partnerContribution>We provide genetics, statistical, bioinformatics, epigenetics, epidemiology and complex disease expertise.</gtr:partnerContribution><gtr:piContribution>This is a JPND Consortium for which I am coordinator</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Sheffield</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Sheffield Institute for Translational Neuroscience (SITraN)</gtr:department><gtr:description>STRENGTH</gtr:description><gtr:id>853C6B16-7794-463F-BE01-6A06D089AE57</gtr:id><gtr:impact>Please see form publications. The collaboration is multidisciplinary including genetics, epidemiology, epigenetics, statistics and bioinformatics</gtr:impact><gtr:outcomeId>545f8a9d977197.00636340-4</gtr:outcomeId><gtr:partnerContribution>We provide genetics, statistical, bioinformatics, epigenetics, epidemiology and complex disease expertise.</gtr:partnerContribution><gtr:piContribution>This is a JPND Consortium for which I am coordinator</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Trinity College Dublin</gtr:collaboratingOrganisation><gtr:country>Ireland, Republic of</gtr:country><gtr:description>STRENGTH</gtr:description><gtr:id>5A205176-ACB6-4B3A-AC1E-2D884FAA7A89</gtr:id><gtr:impact>Please see form publications. The collaboration is multidisciplinary including genetics, epidemiology, epigenetics, statistics and bioinformatics</gtr:impact><gtr:outcomeId>545f8a9d977197.00636340-2</gtr:outcomeId><gtr:partnerContribution>We provide genetics, statistical, bioinformatics, epigenetics, epidemiology and complex disease expertise.</gtr:partnerContribution><gtr:piContribution>This is a JPND Consortium for which I am coordinator</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Leuven</gtr:collaboratingOrganisation><gtr:department>laboratory for cognitive neurology</gtr:department><gtr:description>STRENGTH</gtr:description><gtr:id>810ED0FB-D45B-4F49-838A-37351796CB6A</gtr:id><gtr:impact>Please see form publications. The collaboration is multidisciplinary including genetics, epidemiology, epigenetics, statistics and bioinformatics</gtr:impact><gtr:outcomeId>545f8a9d977197.00636340-5</gtr:outcomeId><gtr:partnerContribution>We provide genetics, statistical, bioinformatics, epigenetics, epidemiology and complex disease expertise.</gtr:partnerContribution><gtr:piContribution>This is a JPND Consortium for which I am coordinator</gtr:piContribution><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Leuven</gtr:collaboratingOrganisation><gtr:country>Belgium, Kingdom of</gtr:country><gtr:department>VIB Vesalius Research Center</gtr:department><gtr:description>ELP3_collaboration</gtr:description><gtr:id>5153BCF8-E1AE-42B9-AF35-429377F4D538</gtr:id><gtr:impact>18996918</gtr:impact><gtr:outcomeId>2919B2EF8C4-1</gtr:outcomeId><gtr:partnerContribution>Development of a zebrafish model of ELP3. Introduction to another group working on fly models. Contribution of human samples.Contribution of human samples. Intellectual support.Contribution of human samplesIntellectual contributionStatistical support and adviceIntellectual contribution</gtr:partnerContribution><gtr:piContribution>Lead for genetic and other analysis, overall strategy, and research direction.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Catholic University of Louvain</gtr:collaboratingOrganisation><gtr:country>Belgium, Kingdom of</gtr:country><gtr:description>STRENGTH</gtr:description><gtr:id>A43600D5-C1E3-4F56-B239-751CE27FA90D</gtr:id><gtr:impact>Please see form publications. The collaboration is multidisciplinary including genetics, epidemiology, epigenetics, statistics and bioinformatics</gtr:impact><gtr:outcomeId>545f8a9d977197.00636340-3</gtr:outcomeId><gtr:partnerContribution>We provide genetics, statistical, bioinformatics, epigenetics, epidemiology and complex disease expertise.</gtr:partnerContribution><gtr:piContribution>This is a JPND Consortium for which I am coordinator</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Utrecht University</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:department>Rudolf Magnus Institute</gtr:department><gtr:description>ELP3_collaboration</gtr:description><gtr:id>4C57B165-EB26-426D-AB54-1F0C592DB0EA</gtr:id><gtr:impact>18996918</gtr:impact><gtr:outcomeId>2919B2EF8C4-3</gtr:outcomeId><gtr:partnerContribution>Development of a zebrafish model of ELP3. Introduction to another group working on fly models. Contribution of human samples.Contribution of human samples. Intellectual support.Contribution of human samplesIntellectual contributionStatistical support and adviceIntellectual contribution</gtr:partnerContribution><gtr:piContribution>Lead for genetic and other analysis, overall strategy, and research direction.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Harvard University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>KIFAP3 consortium</gtr:description><gtr:id>478614D0-DC40-48B0-9A4C-8B9188169045</gtr:id><gtr:impact>Publication: PMID 19451621</gtr:impact><gtr:outcomeId>D175ACA40C6-5</gtr:outcomeId><gtr:partnerContribution>Contribution of samples. Intellectual contribution.Contribution of samples. Contribution of expertise in functional studies.Contribution of samples.Contribution of samples.Intellectual contributionContribution of samples.Intellectual contribution</gtr:partnerContribution><gtr:piContribution>Lead for project. Contribution of samples. Intellectual contribution.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Howard Hughes Medical Institute</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>KIFAP3 consortium</gtr:description><gtr:id>AB15DF11-A347-4CAF-BD74-7BDE90FC784D</gtr:id><gtr:impact>Publication: PMID 19451621</gtr:impact><gtr:outcomeId>D175ACA40C6-7</gtr:outcomeId><gtr:partnerContribution>Contribution of samples. Intellectual contribution.Contribution of samples. Contribution of expertise in functional studies.Contribution of samples.Contribution of samples.Intellectual contributionContribution of samples.Intellectual contribution</gtr:partnerContribution><gtr:piContribution>Lead for project. Contribution of samples. Intellectual contribution.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Milan</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:description>STRENGTH</gtr:description><gtr:id>1FDC0873-2513-45F7-AB9F-6277ACB83A29</gtr:id><gtr:impact>Please see form publications. The collaboration is multidisciplinary including genetics, epidemiology, epigenetics, statistics and bioinformatics</gtr:impact><gtr:outcomeId>545f8a9d977197.00636340-7</gtr:outcomeId><gtr:partnerContribution>We provide genetics, statistical, bioinformatics, epigenetics, epidemiology and complex disease expertise.</gtr:partnerContribution><gtr:piContribution>This is a JPND Consortium for which I am coordinator</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Massachusetts General Hospital</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>KIFAP3 consortium</gtr:description><gtr:id>A0497563-5BE0-4970-AEB0-2A7499C33F36</gtr:id><gtr:impact>Publication: PMID 19451621</gtr:impact><gtr:outcomeId>D175ACA40C6-1</gtr:outcomeId><gtr:partnerContribution>Contribution of samples. Intellectual contribution.Contribution of samples. Contribution of expertise in functional studies.Contribution of samples.Contribution of samples.Intellectual contributionContribution of samples.Intellectual contribution</gtr:partnerContribution><gtr:piContribution>Lead for project. Contribution of samples. Intellectual contribution.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University Medical Center Utrecht (UMC)</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>STRENGTH</gtr:description><gtr:id>D005714A-33E3-4C9E-8CBA-1A3039A914A7</gtr:id><gtr:impact>Please see form publications. The collaboration is multidisciplinary including genetics, epidemiology, epigenetics, statistics and bioinformatics</gtr:impact><gtr:outcomeId>545f8a9d977197.00636340-1</gtr:outcomeId><gtr:partnerContribution>We provide genetics, statistical, bioinformatics, epigenetics, epidemiology and complex disease expertise.</gtr:partnerContribution><gtr:piContribution>This is a JPND Consortium for which I am coordinator</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institute of Health and Medical Research (INSERM)</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:department>Nimes (INSERM)</gtr:department><gtr:description>STRENGTH</gtr:description><gtr:id>EB0EA029-EC7E-4895-BF5E-DAC0E582B7C7</gtr:id><gtr:impact>Please see form publications. The collaboration is multidisciplinary including genetics, epidemiology, epigenetics, statistics and bioinformatics</gtr:impact><gtr:outcomeId>545f8a9d977197.00636340-8</gtr:outcomeId><gtr:partnerContribution>We provide genetics, statistical, bioinformatics, epigenetics, epidemiology and complex disease expertise.</gtr:partnerContribution><gtr:piContribution>This is a JPND Consortium for which I am coordinator</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Catholic University of Louvain</gtr:collaboratingOrganisation><gtr:country>Belgium, Kingdom of</gtr:country><gtr:description>KIFAP3 consortium</gtr:description><gtr:id>94F30382-EB5A-450A-B0C8-E7710F69E2C1</gtr:id><gtr:impact>Publication: PMID 19451621</gtr:impact><gtr:outcomeId>D175ACA40C6-2</gtr:outcomeId><gtr:partnerContribution>Contribution of samples. Intellectual contribution.Contribution of samples. Contribution of expertise in functional studies.Contribution of samples.Contribution of samples.Intellectual contributionContribution of samples.Intellectual contribution</gtr:partnerContribution><gtr:piContribution>Lead for project. Contribution of samples. Intellectual contribution.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University Paris Sud</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:department>University of ?vry Val-d'Essonne</gtr:department><gtr:description>KIFAP3 consortium</gtr:description><gtr:id>58093F0B-1533-433C-AC21-61F9EE81EAE8</gtr:id><gtr:impact>Publication: PMID 19451621</gtr:impact><gtr:outcomeId>D175ACA40C6-3</gtr:outcomeId><gtr:partnerContribution>Contribution of samples. Intellectual contribution.Contribution of samples. Contribution of expertise in functional studies.Contribution of samples.Contribution of samples.Intellectual contributionContribution of samples.Intellectual contribution</gtr:partnerContribution><gtr:piContribution>Lead for project. Contribution of samples. Intellectual contribution.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Harvard University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>ELP3_collaboration</gtr:description><gtr:id>92CE1A7D-47A3-4AD9-8747-E479616CA100</gtr:id><gtr:impact>18996918</gtr:impact><gtr:outcomeId>2919B2EF8C4-4</gtr:outcomeId><gtr:partnerContribution>Development of a zebrafish model of ELP3. Introduction to another group working on fly models. Contribution of human samples.Contribution of human samples. Intellectual support.Contribution of human samplesIntellectual contributionStatistical support and adviceIntellectual contribution</gtr:partnerContribution><gtr:piContribution>Lead for genetic and other analysis, overall strategy, and research direction.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Howard Hughes Medical Institute</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>ELP3_collaboration</gtr:description><gtr:id>CF3517FC-9CC3-43EC-BE4E-8D0FEA8E0353</gtr:id><gtr:impact>18996918</gtr:impact><gtr:outcomeId>2919B2EF8C4-6</gtr:outcomeId><gtr:partnerContribution>Development of a zebrafish model of ELP3. Introduction to another group working on fly models. Contribution of human samples.Contribution of human samples. Intellectual support.Contribution of human samplesIntellectual contributionStatistical support and adviceIntellectual contribution</gtr:partnerContribution><gtr:piContribution>Lead for genetic and other analysis, overall strategy, and research direction.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University Medical Center Utrecht (UMC)</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>KIFAP3 consortium</gtr:description><gtr:id>8D056367-736D-4EA2-BD23-6F20287E8237</gtr:id><gtr:impact>Publication: PMID 19451621</gtr:impact><gtr:outcomeId>D175ACA40C6-4</gtr:outcomeId><gtr:partnerContribution>Contribution of samples. Intellectual contribution.Contribution of samples. Contribution of expertise in functional studies.Contribution of samples.Contribution of samples.Intellectual contributionContribution of samples.Intellectual contribution</gtr:partnerContribution><gtr:piContribution>Lead for project. Contribution of samples. Intellectual contribution.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>European Commission</gtr:collaboratingOrganisation><gtr:country>European Union (EU)</gtr:country><gtr:department>Seventh Framework Programme (FP7)</gtr:department><gtr:description>EuroMOTOR</gtr:description><gtr:id>62896B8F-F1FE-479D-8E49-662FF48B0B5D</gtr:id><gtr:impact>1. Aggregation of neurologic and neuropsychiatric disease in ALS kindreds: A population based case controlled cohort study of Familial and Sporadic ALS.

 Byrne S, Heverin M, Elamin M, Bede P, Lynch C, Kenna K, Maclaughlin R, Walsh C, Al Chalabi A, Hardiman O.
 Ann Neurol. 2013 Jul 9. doi: 10.1002/ana.23969. [Epub ahead of print]
 PMID: 23836460 [PubMed - as supplied by publisher]
 Related citations 

2. Credibility analysis of putative disease-causing genes using bioinformatics.

 Abel O, Powell JF, Andersen PM, Al-Chalabi A.
 PLoS One. 2013 Jun 5;8(6):e64899. doi: 10.1371/journal.pone.0064899. Print 2013.
 PMID: 23755159 [PubMed - in process] Free PMC Article 
 Related citations 

3. Homozygosity analysis in amyotrophic lateral sclerosis.

 Mok K, Laaksovirta H, Tienari PJ, Peuralinna T, Myllykangas L, Chi&amp;ograve; A, Traynor BJ, Nalls MA, Gurunlian N, Shatunov A, Restagno G, Mora G, Nigel Leigh P, Shaw CE, Morrison KE, Shaw PJ, Al-Chalabi A, Hardy J, Orrell RW.
 Eur J Hum Genet. 2013 Apr 24. doi: 10.1038/ejhg.2013.59. [Epub ahead of print]
 PMID: 23612577 [PubMed - as supplied by publisher]
 Related citations 

4. Residual association at C9orf72 suggests an alternative amyotrophic lateral sclerosis-causing hexanucleotide repeat.

 Jones AR, Woollacott I, Shatunov A, Cooper-Knock J, Buchman V, Sproviero W, Smith B, Scott KM, Balendra R, Abel O, McGuffin P, Ellis CM, Shaw PJ, Morrison KE, Farmer A, Lewis CM, Leigh PN, Shaw CE, Powell JF, Al-Chalabi A.
 Neurobiol Aging. 2013 Sep;34(9):2234.e1-7. doi: 10.1016/j.neurobiolaging.2013.03.003. Epub 2013 Apr 12.
 PMID: 23587638 [PubMed - in process]
 Related citations 

5. H63D polymorphism in HFE is not associated with amyotrophic lateral sclerosis.

 van Rheenen W, Diekstra FP, van Doormaal PT, Seelen M, Kenna K, McLaughlin R, Shatunov A, Czell D, van Es MA, van Vught PW, van Damme P, Smith BN, Waibel S, Schelhaas HJ, van der Kooi AJ, de Visser M, Weber M, Robberecht W, Hardiman O, Shaw PJ, Shaw CE, Morrison KE, Al-Chalabi A, Andersen PM, Ludolph AC, Veldink JH, van den Berg LH.
 Neurobiol Aging. 2013 May;34(5):1517.e5-7. doi: 10.1016/j.neurobiolaging.2012.07.020. Epub 2012 Oct 11.
 PMID: 23063643 [PubMed - indexed for MEDLINE]
 Related citations 

6. Is language impairment more common than executive dysfunction in amyotrophic lateral sclerosis?

 Taylor LJ, Brown RG, Tsermentseli S, Al-Chalabi A, Shaw CE, Ellis CM, Leigh PN, Goldstein LH.
 J Neurol Neurosurg Psychiatry. 2013 May;84(5):494-8. doi: 10.1136/jnnp-2012-303526. Epub 2012 Oct 2.
 PMID: 23033353 [PubMed - indexed for MEDLINE]
 Related citations 

7. Age of onset of amyotrophic lateral sclerosis is modulated by a locus on 1p34.1.

 ALSGEN Consortium, Ahmeti KB, Ajroud-Driss S, Al-Chalabi A, Andersen PM, Armstrong J, Birve A, Blauw HM, Brown RH, Bruijn L, Chen W, Chio A, Comeau MC, Cronin S, Diekstra FP, Soraya Gkazi A, Glass JD, Grab JD, Groen EJ, Haines JL, Hardiman O, Heller S, Huang J, Hung WY; ITALSGEN consortium, Jaworski JM, Jones A, Khan H, Landers JE, Langefeld CD, Leigh PN, Marion MC, McLaughlin RL, Meininger V, Melki J, Miller JW, Mora G, Pericak-Vance MA, Rampersaud E, Robberecht W, Russell LP, Salachas F, Saris CG, Shatunov A, Shaw CE, Siddique N, Siddique T, Smith BN, Sufit R, Topp S, Traynor BJ, Vance C, van Damme P, van den Berg LH, van Es MA, van Vught PW, Veldink JH, Yang Y, Zheng JG.
 Neurobiol Aging. 2013 Jan;34(1):357.e7-19. doi: 10.1016/j.neurobiolaging.2012.07.017. Epub 2012 Sep 5.
 PMID: 22959728 [PubMed - indexed for MEDLINE]
 Related citations 

8. EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans.

 Van Hoecke A, Schoonaert L, Lemmens R, Timmers M, Staats KA, Laird AS, Peeters E, Philips T, Goris A, Dubois B, Andersen PM, Al-Chalabi A, Thijs V, Turnley AM, van Vught PW, Veldink JH, Hardiman O, Van Den Bosch L, Gonzalez-Perez P, Van Damme P, Brown RH Jr, van den Berg LH, Robberecht W.
 Nat Med. 2012 Sep;18(9):1418-22.
 PMID: 22922411 [PubMed - indexed for MEDLINE]
 Related citations 

9. A proposed staging system for amyotrophic lateral sclerosis.

Roche JC, Rojas-Garcia R, Scott KM, Scotton W, Ellis CE, Burman R, Wijesekera L, Turner MR, Leigh PN, Shaw CE, Al-Chalabi A.
Brain. 2012 Mar;135(Pt 3):847-52. doi: 10.1093/brain/awr351. Epub 2012 Jan 23.
PMID: 22271664 [PubMed - indexed for MEDLINE] Free PMC Article
Related citations</gtr:impact><gtr:outcomeId>gAU2aFGkAV4-1</gtr:outcomeId><gtr:partnerContribution>Project start was February 2011. Partners have contributed genotype data, DNA, phenotype data and epidemiology data.</gtr:partnerContribution><gtr:piContribution>This is an EU FP7 collaboration that has been awarded funding. We are contributing to the genomics work package.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Karolinska Institute</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:description>STRENGTH</gtr:description><gtr:id>FAE28E5C-0CDC-4CAD-946A-6DCBA67790EF</gtr:id><gtr:impact>Please see form publications. The collaboration is multidisciplinary including genetics, epidemiology, epigenetics, statistics and bioinformatics</gtr:impact><gtr:outcomeId>545f8a9d977197.00636340-10</gtr:outcomeId><gtr:partnerContribution>We provide genetics, statistical, bioinformatics, epigenetics, epidemiology and complex disease expertise.</gtr:partnerContribution><gtr:piContribution>This is a JPND Consortium for which I am coordinator</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Turin</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:description>STRENGTH</gtr:description><gtr:id>7EFE8BB8-534D-4C0F-B9E8-DC6BB20E6900</gtr:id><gtr:impact>Please see form publications. The collaboration is multidisciplinary including genetics, epidemiology, epigenetics, statistics and bioinformatics</gtr:impact><gtr:outcomeId>545f8a9d977197.00636340-6</gtr:outcomeId><gtr:partnerContribution>We provide genetics, statistical, bioinformatics, epigenetics, epidemiology and complex disease expertise.</gtr:partnerContribution><gtr:piContribution>This is a JPND Consortium for which I am coordinator</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Hong Kong</gtr:collaboratingOrganisation><gtr:country>Hong Kong, Special Administrative Region of China</gtr:country><gtr:description>ELP3_collaboration</gtr:description><gtr:id>911EE545-7A55-4BB7-9117-F08F27807702</gtr:id><gtr:impact>18996918</gtr:impact><gtr:outcomeId>2919B2EF8C4-5</gtr:outcomeId><gtr:partnerContribution>Development of a zebrafish model of ELP3. Introduction to another group working on fly models. Contribution of human samples.Contribution of human samples. Intellectual support.Contribution of human samplesIntellectual contributionStatistical support and adviceIntellectual contribution</gtr:partnerContribution><gtr:piContribution>Lead for genetic and other analysis, overall strategy, and research direction.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Massachusetts General Hospital</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>ELP3_collaboration</gtr:description><gtr:id>E6BCD987-9B01-447D-AE2B-F5AEC2A35B29</gtr:id><gtr:impact>18996918</gtr:impact><gtr:outcomeId>2919B2EF8C4-2</gtr:outcomeId><gtr:partnerContribution>Development of a zebrafish model of ELP3. Introduction to another group working on fly models. Contribution of human samples.Contribution of human samples. Intellectual support.Contribution of human samplesIntellectual contributionStatistical support and adviceIntellectual contribution</gtr:partnerContribution><gtr:piContribution>Lead for genetic and other analysis, overall strategy, and research direction.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>BMI The Beaumont Hospital</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>KIFAP3 consortium</gtr:description><gtr:id>6A1EB9CC-7BF1-445E-850F-81EB3C976612</gtr:id><gtr:impact>Publication: PMID 19451621</gtr:impact><gtr:outcomeId>D175ACA40C6-6</gtr:outcomeId><gtr:partnerContribution>Contribution of samples. Intellectual contribution.Contribution of samples. Contribution of expertise in functional studies.Contribution of samples.Contribution of samples.Intellectual contributionContribution of samples.Intellectual contribution</gtr:partnerContribution><gtr:piContribution>Lead for project. Contribution of samples. Intellectual contribution.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Kantonsspital St. Gallen</gtr:collaboratingOrganisation><gtr:country>Switzerland, Swiss Confederation</gtr:country><gtr:description>STRENGTH</gtr:description><gtr:id>F7FDDA6C-D311-4517-A750-542185BA7896</gtr:id><gtr:impact>Please see form publications. The collaboration is multidisciplinary including genetics, epidemiology, epigenetics, statistics and bioinformatics</gtr:impact><gtr:outcomeId>545f8a9d977197.00636340-9</gtr:outcomeId><gtr:partnerContribution>We provide genetics, statistical, bioinformatics, epigenetics, epidemiology and complex disease expertise.</gtr:partnerContribution><gtr:piContribution>This is a JPND Consortium for which I am coordinator</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>MNDA information video on our research</gtr:description><gtr:form>A broadcast e.g. TV/radio/film/podcast (other than news/press)</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>CC5BC5C8-5D6C-492E-94BE-D93CCA212DED</gtr:id><gtr:impact>A YouTube video posted also on the Motor Neurone Disease Association website, describing our research.</gtr:impact><gtr:outcomeId>58a2eb299868a4.07244144</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>https://youtu.be/tKz81aFVB04</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MNDA-sponsored VIP visit</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>9111CD4D-2297-496E-AB09-B9042DC538EC</gtr:id><gtr:impact>Hosted a visit to our labs by key people identified by the Motor Neurone Disease Association

Increased funding to the MNDA. Report from the MNDA describing increased funds as a direct result.</gtr:impact><gtr:outcomeId>81B913DEAC1</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2009,2012,2013,2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Ask the Experts Panel at International Symposium</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>6EA211DF-3C90-42A6-9DCE-496DCC85BA8D</gtr:id><gtr:impact>A live audience and online audience watched a presentation and then asked questions on ALS research</gtr:impact><gtr:outcomeId>58a2ec3fab4506.37085934</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Patients, carers and/or patient groups</gtr:primaryAudience><gtr:url>https://www.youtube.com/watch?v=U98WU4Zzu8s</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Edmond J Safra Memorial Lecture</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>2D1C20BA-E5EB-4DAA-9200-A7EAD46DBD08</gtr:id><gtr:impact>Presentation of research findings to a lay audience of key &amp;quot;high value&amp;quot; individuals, aiming to educate and improve philanthropic investment in research.

None known</gtr:impact><gtr:outcomeId>7655857D051</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>General research dissemination videos on YouTube</gtr:description><gtr:form>A broadcast e.g. TV/radio/film/podcast (other than news/press)</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>CAF2EB01-B541-4879-914C-34B8201104D0</gtr:id><gtr:impact>Multiple videos on YouTube, responding to interviews on ALS research</gtr:impact><gtr:outcomeId>58a2ed187db8e3.61005635</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>https://www.youtube.com/results?search_query=ammar+al-chalabi+als</gtr:url><gtr:year>2014,2015,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Newspaper articles</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>B4A8363A-AC51-4E49-BE16-0CC4E873FE25</gtr:id><gtr:impact>Interviewed by reporters with story on BBC website and others

None evaluated</gtr:impact><gtr:outcomeId>6460BB337CB</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MNDA Newsletter</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>5B1C3873-558D-4F01-ABC2-319C0AC4A3EC</gtr:id><gtr:impact>A report on our research group activities for the MNDA newsletter

None evaluated</gtr:impact><gtr:outcomeId>6C19CA14526</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2008,2009,2013,2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Broadcast news items on new gene discoveries</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>8737038B-14A4-45AC-B2DD-C7D2BE835BD8</gtr:id><gtr:impact>Interviews with BBC World (live TV interview), ITV News (recorded TV), Channel 5 News (recorded TV), BBC Radio London (live radio) and others. Example URL below</gtr:impact><gtr:outcomeId>58a2edfb226ee3.58360770</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>https://twitter.com/ammaralchalabi/status/758321315698933760</gtr:url><gtr:year>2015,2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>530723</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>JPND STRENGTH</gtr:description><gtr:end>2017-01-02</gtr:end><gtr:fundingOrg>JPND Research</gtr:fundingOrg><gtr:fundingRef>MR/L501529/1</gtr:fundingRef><gtr:id>13985D99-A533-4965-B67F-A46179743712</gtr:id><gtr:outcomeId>545f8d453d6eb7.77196932</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>71912</gtr:amountPounds><gtr:country>Unknown</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Angel Fund, Project Grant (GWAS in ALS)</gtr:description><gtr:end>2009-12-02</gtr:end><gtr:fundingOrg>Angel Fund</gtr:fundingOrg><gtr:id>9AE2312C-AC78-4A23-8DE6-EFE7B6993A94</gtr:id><gtr:outcomeId>AE2A47BDF630</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MNDA Project Grant (KIFAP3 in ALS)</gtr:description><gtr:end>2014-11-02</gtr:end><gtr:fundingOrg>Motor Neurone Disease Association (MND)</gtr:fundingOrg><gtr:id>E0F7A370-654D-47F7-B5AC-474C3E87C381</gtr:id><gtr:outcomeId>4172F1330E60</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>147613</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>ALS Therapy Project Grant (GWAS in ALS)</gtr:description><gtr:end>2013-03-02</gtr:end><gtr:fundingOrg>ALS Therapy Alliance</gtr:fundingOrg><gtr:id>94599029-2A41-4BA8-863D-7A068DBAD8AD</gtr:id><gtr:outcomeId>817FDD14F160</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>40000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>ALSA Funder-initiated project grant (ALSOD website and database)/ALS Association</gtr:description><gtr:end>2011-02-02</gtr:end><gtr:fundingOrg>ALS Association</gtr:fundingOrg><gtr:id>C7003F71-D044-49F3-92ED-3D86478E9F0C</gtr:id><gtr:outcomeId>odxa2r8tzPJ0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>520688</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Strategic Grant (Next generation gene hunting in ALS - coapplicant)</gtr:description><gtr:end>2011-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>10533456-B6FF-4AF0-8458-808381C9AA0C</gtr:id><gtr:outcomeId>69DFD44998D0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>102000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MNDA Project Grant (ELP3 in ALS)</gtr:description><gtr:end>2012-04-02</gtr:end><gtr:fundingOrg>Motor Neurone Disease Association (MND)</gtr:fundingOrg><gtr:id>BB702626-B88E-45F1-8838-2E12ABFCB718</gtr:id><gtr:outcomeId>6022F9AFB410</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>48000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC DTA Studentship (The transcriptome in ALS)</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>C491D810-D03F-40CF-8849-75C960683BBC</gtr:id><gtr:outcomeId>MPCgYzSqAA70</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Contributor and editor of laboratory manual on complex disease genetics</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>6C1E5003-3A15-4BD8-A235-CEB539BC7A5E</gtr:id><gtr:outcomeId>GYqYMpfkREB</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>An online resource for genetic studies of ALS with research tools and links to bioinformatics resources at http://alsod.iop.kcl.ac.uk</gtr:description><gtr:id>0D96E999-A6C4-4B2E-BB0F-9B85C1861A9A</gtr:id><gtr:impact>Website is visited 9000 times a month on average.</gtr:impact><gtr:outcomeId>88776A8B589</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>ALSOD</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:url>http://alsod.iop.kcl.ac.uk</gtr:url><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Genotypes from ALS patients and controls</gtr:description><gtr:id>09A280E6-48A3-4748-A58C-61EA92F73509</gtr:id><gtr:impact>Discovery and reporting of new genes and loci for ALS. Discovery of a locus on chromosome 9 associated with ALS. This directly led to the identification of the C9orf72 gene expansion mutation in ALS, which is the commonest cause of ALS (about 10% in the UK).</gtr:impact><gtr:outcomeId>206AB053D1B</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>GWAS data</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>2A6A4DE2-F9F5-4B79-B5BA-4C70C85C86CB</gtr:id><gtr:title>Rare genetic variation in UNC13A may modify survival in amyotrophic lateral sclerosis.</gtr:title><gtr:parentPublicationTitle>Amyotrophic lateral sclerosis &amp; frontotemporal degeneration</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a6e554bc59d628ea7e59537f8090ec1c"><gtr:id>a6e554bc59d628ea7e59537f8090ec1c</gtr:id><gtr:otherNames>Gaastra B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2167-8421</gtr:issn><gtr:outcomeId>58a2d69a1cd4d5.90060636</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>41B4F1B3-469D-4B53-9C98-1EB76F4ECCC0</gtr:id><gtr:title>Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a9310cf284c8313db35d3785d3e32077"><gtr:id>a9310cf284c8313db35d3785d3e32077</gtr:id><gtr:otherNames>Harold D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>9B02971B1CB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9935A348-E415-45BA-95E4-7A7BE6C42EEE</gtr:id><gtr:title>Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/59ac40b969c64db850e438e12bb3e323"><gtr:id>59ac40b969c64db850e438e12bb3e323</gtr:id><gtr:otherNames>Jones L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>CFcmT9xYnnF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F9DDC086-3C06-4814-A97E-242E1AF8D294</gtr:id><gtr:title>ALSOD: the Amyotrophic Lateral Sclerosis Online Database.</gtr:title><gtr:parentPublicationTitle>Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3f8ce93db4a227f5353a89a0c28ed415"><gtr:id>3f8ce93db4a227f5353a89a0c28ed415</gtr:id><gtr:otherNames>Wroe R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1471-180X</gtr:issn><gtr:outcomeId>479A1852DF0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1AA752A9-9E19-4376-A49B-AEF9BA46B89E</gtr:id><gtr:title>Polymorphisms in the GluR2 gene are not associated with amyotrophic lateral sclerosis.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ea19fc76f7804dd1a81c51c7e7996ae7"><gtr:id>ea19fc76f7804dd1a81c51c7e7996ae7</gtr:id><gtr:otherNames>Bogaert E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>qZf57myJNC5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>74477254-0DDE-4889-9619-0C2C5B6CF68C</gtr:id><gtr:title>Reduced expression of the Kinesin-Associated Protein 3 (KIFAP3) gene increases survival in sporadic amyotrophic lateral sclerosis.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e078c74958f5d34c29d138c303e544f8"><gtr:id>e078c74958f5d34c29d138c303e544f8</gtr:id><gtr:otherNames>Landers JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>1E36DB195F7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>31BD25DD-F7AB-44AB-889A-1BC62D5B31CA</gtr:id><gtr:title>The C9ORF72 expansion mutation is a common cause of ALS+/-FTD in Europe and has a single founder.</gtr:title><gtr:parentPublicationTitle>European journal of human genetics : EJHG</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/90509523adb96ea1aa3696ac87c9450d"><gtr:id>90509523adb96ea1aa3696ac87c9450d</gtr:id><gtr:otherNames>Smith BN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1018-4813</gtr:issn><gtr:outcomeId>544bcf013e1c05.46260780</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B0CD5EEC-0F23-4792-A6E0-40119F16F51D</gtr:id><gtr:title>A comprehensive analysis of rare genetic variation in amyotrophic lateral sclerosis in the UK.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aa2841aab396cd2b4f18a94e7a29ae23"><gtr:id>aa2841aab396cd2b4f18a94e7a29ae23</gtr:id><gtr:otherNames>Morgan S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>5a952c5073e833.70304743</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B0C83E3E-A857-45F7-AFF8-59A52B40BC58</gtr:id><gtr:title>Health utility decreases with increasing clinical stage in amyotrophic lateral sclerosis.</gtr:title><gtr:parentPublicationTitle>Amyotrophic lateral sclerosis &amp; frontotemporal degeneration</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/189b1ab3fec05c8e5670388f3356335d"><gtr:id>189b1ab3fec05c8e5670388f3356335d</gtr:id><gtr:otherNames>Jones AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2167-8421</gtr:issn><gtr:outcomeId>545f87fd5d16b2.20381782</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>90BF3760-DD5A-4BAB-89C1-1167682A04F9</gtr:id><gtr:title>Targeted Genetic Screen in Amyotrophic Lateral Sclerosis Reveals Novel Genetic Variants with Synergistic Effect on Clinical Phenotype.</gtr:title><gtr:parentPublicationTitle>Frontiers in molecular neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5bb0f592e8014472d5082208157baad"><gtr:id>c5bb0f592e8014472d5082208157baad</gtr:id><gtr:otherNames>Cooper-Knock J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1662-5099</gtr:issn><gtr:outcomeId>5a952c51458230.49094954</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9DCC0B1F-3AFA-4088-8BE6-2578D734E00E</gtr:id><gtr:title>Modelling C9ORF72 hexanucleotide repeat expansion in amyotrophic lateral sclerosis and frontotemporal dementia.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6a46cc13f73dd87b9293e1cd22958c7c"><gtr:id>6a46cc13f73dd87b9293e1cd22958c7c</gtr:id><gtr:otherNames>Stepto A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn><gtr:outcomeId>pm_540e16ae16a979aa1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7A4112E3-82E3-4D4D-A001-E24A6FA84DDD</gtr:id><gtr:title>Meta-analysis of pharmacogenetic interactions in amyotrophic lateral sclerosis clinical trials.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/648ce689029eb74519bb3610828d1173"><gtr:id>648ce689029eb74519bb3610828d1173</gtr:id><gtr:otherNames>van Eijk RPA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>5aa699e5ebbea6.81534669</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1665914F-D854-4435-BD6E-FF74AC7E0DC5</gtr:id><gtr:title>Amyotrophic lateral sclerosis.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a885c902c57eeb35d266c592227182d7"><gtr:id>a885c902c57eeb35d266c592227182d7</gtr:id><gtr:otherNames>van Es MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>5a952c5044d435.82097316</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2C25E276-C40F-44CE-9B3B-17676F1A8866</gtr:id><gtr:title>An estimate of amyotrophic lateral sclerosis heritability using twin data.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d7bc8538c82db76d6e2482ddeeb2d3d0"><gtr:id>d7bc8538c82db76d6e2482ddeeb2d3d0</gtr:id><gtr:otherNames>Al-Chalabi A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>qJgR47agCMR</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D425DB0A-A503-423E-BEC5-27AF4CEEB90B</gtr:id><gtr:title>NEK1 variants confer susceptibility to amyotrophic lateral sclerosis.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aa8dc20d96363a2f4e574a132c76feaf"><gtr:id>aa8dc20d96363a2f4e574a132c76feaf</gtr:id><gtr:otherNames>Kenna KP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>58a2d861aa1905.68112376</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0A6B32AB-CA32-4519-8D16-567A5AE73B01</gtr:id><gtr:title>A genome-wide association meta-analysis identifies a novel locus at 17q11.2 associated with sporadic amyotrophic lateral sclerosis.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/68ae0b5920edebc0579f77ebe7ddbb4e"><gtr:id>68ae0b5920edebc0579f77ebe7ddbb4e</gtr:id><gtr:otherNames>Fogh I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>544bcf02883315.60737102</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>69E19CC2-391D-47EA-8BC4-CE2CC18BA6AA</gtr:id><gtr:title>Differential roles of the ubiquitin proteasome system and autophagy in the clearance of soluble and aggregated TDP-43 species.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2f5ee2d92393641a7087d03d8fb52781"><gtr:id>2f5ee2d92393641a7087d03d8fb52781</gtr:id><gtr:otherNames>Scotter EL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>544bcf02dec130.64984146</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0CEB8BAB-AC81-4468-8BB7-B37FF192A1AA</gtr:id><gtr:title>ATXN2 trinucleotide repeat length correlates with risk of ALS.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fdc6e29ff1fbfb82d08db9aa811d9c11"><gtr:id>fdc6e29ff1fbfb82d08db9aa811d9c11</gtr:id><gtr:otherNames>Sproviero W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>5aa699e29b59d1.36739737</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4A50220F-88BB-456D-A7F1-BA0930A4E60F</gtr:id><gtr:title>Homozygosity analysis in amyotrophic lateral sclerosis.</gtr:title><gtr:parentPublicationTitle>European journal of human genetics : EJHG</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb5ecebb0a95326732850cb51e132dc6"><gtr:id>bb5ecebb0a95326732850cb51e132dc6</gtr:id><gtr:otherNames>Mok K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1018-4813</gtr:issn><gtr:outcomeId>544bcf01c66b68.28467340</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8F507A75-F85A-4986-8002-7849523F767E</gtr:id><gtr:title>No evidence for shared genetic basis of common variants in multiple sclerosis and amyotrophic lateral sclerosis.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cc23875dbdf591dfec98dd2283598bc3"><gtr:id>cc23875dbdf591dfec98dd2283598bc3</gtr:id><gtr:otherNames>Goris A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>544bcf0257e9b7.52663862</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>90DD848D-8A0B-487E-9C88-D059C23A79F4</gtr:id><gtr:title>Molecular insights and therapeutic targets in amyotrophic lateral sclerosis.</gtr:title><gtr:parentPublicationTitle>CNS &amp; neurological disorders drug targets</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0737bcb5a8ebef94755f6214dfe82972"><gtr:id>0737bcb5a8ebef94755f6214dfe82972</gtr:id><gtr:otherNames>Tripathi VB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1871-5273</gtr:issn><gtr:outcomeId>7D3EEF22605</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CBFFAD3A-ED6C-45C4-9A65-3666B34D9214</gtr:id><gtr:title>RNA Misprocessing in-Linked Neurodegeneration.</gtr:title><gtr:parentPublicationTitle>Frontiers in cellular neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9adb0cf9c748d2062adf63457cc15ba4"><gtr:id>9adb0cf9c748d2062adf63457cc15ba4</gtr:id><gtr:otherNames>Barker HV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1662-5102</gtr:issn><gtr:outcomeId>5aa699e5738790.24080771</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A91BDE4E-5A6B-4B37-ADFD-6B7FE9E8A98F</gtr:id><gtr:title>Autosomal dominant inheritance of rapidly progressive amyotrophic lateral sclerosis due to a truncation mutation in the fused in sarcoma (FUS) gene.</gtr:title><gtr:parentPublicationTitle>Amyotrophic lateral sclerosis &amp; frontotemporal degeneration</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4764aa823b7a020b3590bce2cc799303"><gtr:id>4764aa823b7a020b3590bce2cc799303</gtr:id><gtr:otherNames>Kent L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2167-8421</gtr:issn><gtr:outcomeId>544bcf045a5fe5.17451079</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>36FBFF67-F681-4823-BB1C-001822F2C900</gtr:id><gtr:title>C9orf72 and UNC13A are shared risk loci for amyotrophic lateral sclerosis and frontotemporal dementia: a genome-wide meta-analysis.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/93dc99c98b59b49150ea537d5c4c070a"><gtr:id>93dc99c98b59b49150ea537d5c4c070a</gtr:id><gtr:otherNames>Diekstra FP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>544bcf04854020.50255754</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>00AE7940-8AE3-4A0D-A661-B74798391C6C</gtr:id><gtr:title>A large genome scan for rare CNVs in amyotrophic lateral sclerosis.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1cf6adf84ee5e37aa28e6860469210e9"><gtr:id>1cf6adf84ee5e37aa28e6860469210e9</gtr:id><gtr:otherNames>Blauw HM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>DVg4doaLHxG</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9B3A5F1B-ECFE-4211-B573-D00D29601225</gtr:id><gtr:title>Mutations in the vesicular trafficking protein annexin A11 are associated with amyotrophic lateral sclerosis.</gtr:title><gtr:parentPublicationTitle>Science translational medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/90509523adb96ea1aa3696ac87c9450d"><gtr:id>90509523adb96ea1aa3696ac87c9450d</gtr:id><gtr:otherNames>Smith BN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1946-6234</gtr:issn><gtr:outcomeId>5a952c50a55d64.44676013</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>47B19215-9DB4-4CF9-B102-072B7B74BA4E</gtr:id><gtr:title>Tar DNA-binding protein-43 (TDP-43) regulates axon growth in vitro and in vivo.</gtr:title><gtr:parentPublicationTitle>Neurobiology of disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0737bcb5a8ebef94755f6214dfe82972"><gtr:id>0737bcb5a8ebef94755f6214dfe82972</gtr:id><gtr:otherNames>Tripathi VB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0969-9961</gtr:issn><gtr:outcomeId>pm_540e16ae16aa32be5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EF31A56B-588D-420F-BE6B-389D0FD087B7</gtr:id><gtr:title>TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d3e7348e74b192a401350c369dd08145"><gtr:id>d3e7348e74b192a401350c369dd08145</gtr:id><gtr:otherNames>Sreedharan J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>973596FA53E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2D4143F5-445F-4582-A027-70BD83BD02C5</gtr:id><gtr:title>Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a885c902c57eeb35d266c592227182d7"><gtr:id>a885c902c57eeb35d266c592227182d7</gtr:id><gtr:otherNames>van Es MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>27262586068</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3CE2143C-1957-4C73-BD83-7FDC3FC528C5</gtr:id><gtr:title>Use of clinical staging in amyotrophic lateral sclerosis for phase 3 clinical trials.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb87f110bb4914af0973f4d8272af1b6"><gtr:id>bb87f110bb4914af0973f4d8272af1b6</gtr:id><gtr:otherNames>Balendra R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>545f87fcb61572.96405314</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9D03A1E8-5E82-4BF8-81E9-BD50DFA089A5</gtr:id><gtr:title>Analysis of the KIFAP3 gene in amyotrophic lateral sclerosis: a multicenter survival study.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/36c3adde95b35645cd08a001ea45bac2"><gtr:id>36c3adde95b35645cd08a001ea45bac2</gtr:id><gtr:otherNames>van Doormaal PT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>545f886663c0f9.49196297</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>46E1B2DB-29B1-4923-8163-9792DDDA6A30</gtr:id><gtr:title>Evidence of an environmental effect on survival in ALS.</gtr:title><gtr:parentPublicationTitle>Amyotrophic lateral sclerosis &amp; frontotemporal degeneration</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4c398b2323889da25d02c67f44bc8075"><gtr:id>4c398b2323889da25d02c67f44bc8075</gtr:id><gtr:otherNames>Keren N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2167-8421</gtr:issn><gtr:outcomeId>545f88668aead8.28750753</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D09FB98E-BD5B-4757-88D9-08A67D08BD57</gtr:id><gtr:title>Exome-wide rare variant analysis identifies TUBA4A mutations associated with familial ALS.</gtr:title><gtr:parentPublicationTitle>Neuron</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/90509523adb96ea1aa3696ac87c9450d"><gtr:id>90509523adb96ea1aa3696ac87c9450d</gtr:id><gtr:otherNames>Smith BN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0896-6273</gtr:issn><gtr:outcomeId>545f88674b8892.08246452</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>173F7D97-FC1B-47F9-B9D0-43838C5F4737</gtr:id><gtr:title>The benefit of evolving multidisciplinary care in ALS: a diagnostic cohort survival comparison.</gtr:title><gtr:parentPublicationTitle>Amyotrophic lateral sclerosis &amp; frontotemporal degeneration</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9aa73e328eb61ebd7307a45f0b5976b5"><gtr:id>9aa73e328eb61ebd7307a45f0b5976b5</gtr:id><gtr:otherNames>Martin S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2167-8421</gtr:issn><gtr:outcomeId>5aa699e4e53521.11586011</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>80AF638E-3732-474A-AA0C-808448395135</gtr:id><gtr:title>The role of copy number variation in susceptibility to amyotrophic lateral sclerosis: genome-wide association study and comparison with published loci.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a94bd817e0697ab1ede1ac552afec188"><gtr:id>a94bd817e0697ab1ede1ac552afec188</gtr:id><gtr:otherNames>Wain LV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>6F8BEDF7D89</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>74F66542-A3DB-4C7C-A1B9-B97EBBA2826C</gtr:id><gtr:title>Neuromuscular disease: new insights and avenues for therapy.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2f5ee2d92393641a7087d03d8fb52781"><gtr:id>2f5ee2d92393641a7087d03d8fb52781</gtr:id><gtr:otherNames>Scotter EL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>544bcf019cb4a7.27593700</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3A017C51-41F7-4822-BA7D-217630ADD613</gtr:id><gtr:title>Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9da89c318f56fc7256d9d74b60d23229"><gtr:id>9da89c318f56fc7256d9d74b60d23229</gtr:id><gtr:otherNames>Sims R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>5aa699e46a4a55.51168519</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>86161920-217D-4EF7-A458-4AC42582D4AA</gtr:id><gtr:title>A blinded international study on the reliability of genetic testing for GGGGCC-repeat expansions in C9orf72 reveals marked differences in results among 14 laboratories.</gtr:title><gtr:parentPublicationTitle>Journal of medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ac5f45d8a5f9965eb360b3f6697fe0a9"><gtr:id>ac5f45d8a5f9965eb360b3f6697fe0a9</gtr:id><gtr:otherNames>Akimoto C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-2593</gtr:issn><gtr:outcomeId>544bcf03a36e01.94761814</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3F73D0B7-F3E3-43E5-AED3-2E0A885D9F19</gtr:id><gtr:title>A comprehensive analysis of rare genetic variation in amyotrophic lateral sclerosis in the UK.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aa2841aab396cd2b4f18a94e7a29ae23"><gtr:id>aa2841aab396cd2b4f18a94e7a29ae23</gtr:id><gtr:otherNames>Morgan S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>5aa699e3d49b28.83252519</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1CF952A9-8C39-450D-B415-AED2E47A5965</gtr:id><gtr:title>Analysis of the hexanucleotide repeat expansion and founder haplotype at C9ORF72 in an Irish psychosis case-control sample.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7f3e69280e509447cb3979a4a1ea1d93"><gtr:id>7f3e69280e509447cb3979a4a1ea1d93</gtr:id><gtr:otherNames>Fahey C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>545f87fc897255.19642799</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>453C3EDC-95AC-462A-A597-AEC63B41C54B</gtr:id><gtr:title>Genetic correlation between amyotrophic lateral sclerosis and schizophrenia.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/150e9e10e3ebe78c54e55b675bce02c7"><gtr:id>150e9e10e3ebe78c54e55b675bce02c7</gtr:id><gtr:otherNames>McLaughlin RL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>5a952c50e53794.65775672</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F179C1EE-ACB0-41F9-927D-17BDC5FE72E8</gtr:id><gtr:title>Mapping of gene expression reveals CYP27A1 as a susceptibility gene for sporadic ALS.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/93dc99c98b59b49150ea537d5c4c070a"><gtr:id>93dc99c98b59b49150ea537d5c4c070a</gtr:id><gtr:otherNames>Diekstra FP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>544bcf00f13c98.09263733</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A4653630-B3CF-4A6A-AECB-1C31A527E5F3</gtr:id><gtr:title>Measuring reliable change in cognition using the Edinburgh Cognitive and Behavioural ALS Screen (ECAS).</gtr:title><gtr:parentPublicationTitle>Amyotrophic lateral sclerosis &amp; frontotemporal degeneration</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7a1c3a4f7104f5aeaea8e8458de38e30"><gtr:id>7a1c3a4f7104f5aeaea8e8458de38e30</gtr:id><gtr:otherNames>Crockford C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>2167-8421</gtr:issn><gtr:outcomeId>5a952c501667c1.34160462</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>147BDC8B-7825-4F45-B301-F65B304D9B9E</gtr:id><gtr:title>A large-scale international meta-analysis of paraoxonase gene polymorphisms in sporadic ALS.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b676a228ca42acafedbad61b533efdcc"><gtr:id>b676a228ca42acafedbad61b533efdcc</gtr:id><gtr:otherNames>Wills AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>F37B0C0E424</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2CBDE910-81FF-4D60-A3C7-6FBE35EA685A</gtr:id><gtr:title>Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/107e692c5cbfdd08a4bdfa319afca3cb"><gtr:id>107e692c5cbfdd08a4bdfa319afca3cb</gtr:id><gtr:otherNames>Vance C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>1ECA42D1FEE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1F2B7756-8683-4B96-9E8E-E820402BADEA</gtr:id><gtr:title>Chromosome 9p21 in sporadic amyotrophic lateral sclerosis in the UK and seven other countries: a genome-wide association study.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/de2408812a9d6aa79cb920c86fdae47f"><gtr:id>de2408812a9d6aa79cb920c86fdae47f</gtr:id><gtr:otherNames>Shatunov A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>ESTCtrqZ76Y</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>859B9C73-0E27-42D2-B278-9FDB29D29C31</gtr:id><gtr:title>An evaluation of a SVA retrotransposon in the FUS promoter as a transcriptional regulator and its association to ALS.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3108c31a0519408ba70fe51961bbba10"><gtr:id>3108c31a0519408ba70fe51961bbba10</gtr:id><gtr:otherNames>Savage AL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>544bcf03736d30.04611140</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8C5FAC91-8086-497E-8E04-E639B508B101</gtr:id><gtr:title>The evaluation of pain in amyotrophic lateral sclerosis: a case controlled observational study.</gtr:title><gtr:parentPublicationTitle>Amyotrophic lateral sclerosis &amp; frontotemporal degeneration</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3a2bfcf87c109841d4d8f80742db55e3"><gtr:id>3a2bfcf87c109841d4d8f80742db55e3</gtr:id><gtr:otherNames>Wallace VC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2167-8421</gtr:issn><gtr:outcomeId>545f8866de3cc7.85319985</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BB50CA3C-C61F-4D46-8E81-296F4496354A</gtr:id><gtr:title>Unpicking neurodegeneration in a dish with human pluripotent stem cells: one cell type at a time.</gtr:title><gtr:parentPublicationTitle>Cell cycle (Georgetown, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c0033dc734f06165d7061a9236c4adef"><gtr:id>c0033dc734f06165d7061a9236c4adef</gtr:id><gtr:otherNames>Bilican B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1551-4005</gtr:issn><gtr:outcomeId>544bcf0229e0f0.81404388</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ED6B0F40-BF26-43AD-BF40-39B2ADA51BF6</gtr:id><gtr:title>Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6883810a16e61c37ff340736f6cdf792"><gtr:id>6883810a16e61c37ff340736f6cdf792</gtr:id><gtr:otherNames>van Rheenen W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>58a2d7f849c822.53353278</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>76E58DAC-048F-4CA7-9512-71AC5CDD5E2C</gtr:id><gtr:title>Axonal transport of TDP-43 mRNA granules is impaired by ALS-causing mutations.</gtr:title><gtr:parentPublicationTitle>Neuron</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6ecfd0497d0375c0a88359b331f4d279"><gtr:id>6ecfd0497d0375c0a88359b331f4d279</gtr:id><gtr:otherNames>Alami NH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0896-6273</gtr:issn><gtr:outcomeId>544bcf031799a2.08217536</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>854F7283-F19F-444E-B4AD-D93920D42550</gtr:id><gtr:title>Estimating clinical stage of amyotrophic lateral sclerosis from the ALS Functional Rating Scale.</gtr:title><gtr:parentPublicationTitle>Amyotrophic lateral sclerosis &amp; frontotemporal degeneration</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb87f110bb4914af0973f4d8272af1b6"><gtr:id>bb87f110bb4914af0973f4d8272af1b6</gtr:id><gtr:otherNames>Balendra R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2167-8421</gtr:issn><gtr:outcomeId>544bcf03ce0f01.11996138</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B47ACE8A-6451-4639-8A91-B71A408CA1A7</gtr:id><gtr:title>Gene discovery in amyotrophic lateral sclerosis: implications for clinical management.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d7bc8538c82db76d6e2482ddeeb2d3d0"><gtr:id>d7bc8538c82db76d6e2482ddeeb2d3d0</gtr:id><gtr:otherNames>Al-Chalabi A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1759-4758</gtr:issn><gtr:outcomeId>58a2d505b97122.41464612</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B7AAA85F-B2EE-4E71-B59F-3A2B2A11599F</gtr:id><gtr:title>A common haplotype within the PON1 promoter region is associated with sporadic ALS.</gtr:title><gtr:parentPublicationTitle>Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e078c74958f5d34c29d138c303e544f8"><gtr:id>e078c74958f5d34c29d138c303e544f8</gtr:id><gtr:otherNames>Landers JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1471-180X</gtr:issn><gtr:outcomeId>854B4148AAE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B7ACD9AC-A493-44EA-A8D2-3D93D43CC8E3</gtr:id><gtr:title>Genetic studies of amyotrophic lateral sclerosis: controversies and perspectives.</gtr:title><gtr:parentPublicationTitle>Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/faf05dfb3875372b9803843d0c948b15"><gtr:id>faf05dfb3875372b9803843d0c948b15</gtr:id><gtr:otherNames>Beleza-Meireles A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1471-180X</gtr:issn><gtr:outcomeId>0FF0502C5B7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D764EC3E-F298-4D16-BA06-45019C044E4D</gtr:id><gtr:title>Rare missense variants of neuronal nicotinic acetylcholine receptor altering receptor function are associated with sporadic amyotrophic lateral sclerosis.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/44fbba2683a25b06c40b8b064bf3ccfc"><gtr:id>44fbba2683a25b06c40b8b064bf3ccfc</gtr:id><gtr:otherNames>Sabatelli M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>1AE9B2E58E0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6B36DE28-08D7-4E3D-ABFD-DCFAF26D592A</gtr:id><gtr:title>Hexanucleotide repeats in ALS/FTD form length-dependent RNA foci, sequester RNA binding proteins, and are neurotoxic.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1c831250c6d5af43302dbd12e99b4fb6"><gtr:id>1c831250c6d5af43302dbd12e99b4fb6</gtr:id><gtr:otherNames>Lee YB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>pm_540e16ae16a8e0adb</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CC1BFB2A-8F7F-4410-9CE5-8A4C8094DE1D</gtr:id><gtr:title>ECAS A-B-C: alternate forms of the Edinburgh Cognitive and Behavioural ALS Screen.</gtr:title><gtr:parentPublicationTitle>Amyotrophic lateral sclerosis &amp; frontotemporal degeneration</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/455ef8efa672886fda5e194a1e51f698"><gtr:id>455ef8efa672886fda5e194a1e51f698</gtr:id><gtr:otherNames>Crockford CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>2167-8421</gtr:issn><gtr:outcomeId>5a952c4fd11e84.04323575</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F5E59627-4EE0-40DF-9E97-820C450CBD2C</gtr:id><gtr:title>ER-mitochondria associations are regulated by the VAPB-PTPIP51 interaction and are disrupted by ALS/FTD-associated TDP-43.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/77bcf36f991f182856eac148a0a0aa02"><gtr:id>77bcf36f991f182856eac148a0a0aa02</gtr:id><gtr:otherNames>Stoica R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>544bcf042f8d38.13230496</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3EBB3278-6C21-474D-A8CC-42F083D70308</gtr:id><gtr:title>Variants of the elongator protein 3 (ELP3) gene are associated with motor neuron degeneration.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9dac006df65aa6fc3664b1b55668fc4f"><gtr:id>9dac006df65aa6fc3664b1b55668fc4f</gtr:id><gtr:otherNames>Simpson CL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>2DA7AF63D5E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>39780D97-67DF-4E6B-A0FA-94992CD15BB7</gtr:id><gtr:title>Association of a Locus in the CAMTA1 Gene With Survival in Patients With Sporadic Amyotrophic Lateral Sclerosis.</gtr:title><gtr:parentPublicationTitle>JAMA neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/68ae0b5920edebc0579f77ebe7ddbb4e"><gtr:id>68ae0b5920edebc0579f77ebe7ddbb4e</gtr:id><gtr:otherNames>Fogh I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2168-6149</gtr:issn><gtr:outcomeId>58a2da95c283c4.62924411</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C6798559-0E16-4EE5-AC86-7B2199E90941</gtr:id><gtr:title>C9orf72 expansion differentially affects males with spinal onset amyotrophic lateral sclerosis.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4bc40f7ec51e8c45e1a0d464e57ce8e5"><gtr:id>4bc40f7ec51e8c45e1a0d464e57ce8e5</gtr:id><gtr:otherNames>Rooney J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>58a2d5bd6dca00.65121282</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BE488282-128E-4CE9-BCCD-A982E7991BB6</gtr:id><gtr:title>Age of onset of amyotrophic lateral sclerosis is modulated by a locus on 1p34.1.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7c3f5a5bc7ae9744e72b93546e48cb6f"><gtr:id>7c3f5a5bc7ae9744e72b93546e48cb6f</gtr:id><gtr:otherNames>Ahmeti KB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>544bcf016e38a3.28501419</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BE9B1913-3A70-404B-92EE-DC8460706E5E</gtr:id><gtr:title>Elongator subunit 3 (ELP3) modifies ALS through tRNA modification.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e3f91f5337bdb75081843c0f4fce157d"><gtr:id>e3f91f5337bdb75081843c0f4fce157d</gtr:id><gtr:otherNames>Bento-Abreu A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>5a952c4f87d335.75359007</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C0461428-5134-4608-9D3B-F9E723F72726</gtr:id><gtr:title>Comment on &amp;quot;Drug screening for ALS using patient-specific induced pluripotent stem cells&amp;quot;.</gtr:title><gtr:parentPublicationTitle>Science translational medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c0033dc734f06165d7061a9236c4adef"><gtr:id>c0033dc734f06165d7061a9236c4adef</gtr:id><gtr:otherNames>Bilican B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1946-6234</gtr:issn><gtr:outcomeId>544bcf01f119e7.52699369</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8EB3892A-D4B8-4A87-AE82-5A4281D91CFD</gtr:id><gtr:title>Mutations in the vesicular trafficking protein annexin A11 are associated with amyotrophic lateral sclerosis.</gtr:title><gtr:parentPublicationTitle>Science translational medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/90509523adb96ea1aa3696ac87c9450d"><gtr:id>90509523adb96ea1aa3696ac87c9450d</gtr:id><gtr:otherNames>Smith BN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1946-6234</gtr:issn><gtr:outcomeId>5aa699e3687533.67844697</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F799286A-9F89-4DD3-AB04-8B5B0753333B</gtr:id><gtr:title>Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d7bc8538c82db76d6e2482ddeeb2d3d0"><gtr:id>d7bc8538c82db76d6e2482ddeeb2d3d0</gtr:id><gtr:otherNames>Al-Chalabi A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>545f886725c9e6.48809756</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DE606432-EE79-4047-B2F7-9E44E438B06A</gtr:id><gtr:title>Interaction between PON1 and population density in amyotrophic lateral sclerosis.</gtr:title><gtr:parentPublicationTitle>Neuroreport</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/93dc99c98b59b49150ea537d5c4c070a"><gtr:id>93dc99c98b59b49150ea537d5c4c070a</gtr:id><gtr:otherNames>Diekstra FP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0959-4965</gtr:issn><gtr:outcomeId>7A6396C2BC7</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0600974</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>